MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide): The Gold-Standard Tetrazolium Salt for In Vitro Cell Viability Assays

Executive Summary: MTT, supplied as SKU B7777 by APExBIO, is a cationic tetrazolium salt optimized for colorimetric detection of cellular metabolic activity in vitro. Reduction of MTT is primarily mediated by NADH-dependent mitochondrial oxidoreductases, correlating with viable cell count in a quantitative manner (Chen et al., 2023). The compound is highly soluble in DMSO (≥41.4 mg/mL), ethanol (≥18.63 mg/mL), and water (≥2.5 mg/mL with sonication), and must be stored at −20°C for maximal stability. Its robust performance and reproducibility have established MTT as the gold standard for in vitro cell proliferation and apoptosis assays [site article]. MTT’s direct reduction, high purity (≥98%), and membrane permeability distinguish it from second-generation tetrazolium salts (APExBIO B7777).

Biological Rationale

Cell viability assays are central to quantitative biology, toxicology, and drug discovery. Accurate assessment of cell health and metabolic activity is required to screen anti-cancer compounds, evaluate cytotoxicity, and monitor apoptosis [site article]. MTT, a tetrazolium salt, is specifically designed for in vitro assessment because its reduction occurs only in metabolically active, viable cells [site article]. This specificity enables high-throughput, quantitative measurement of cell proliferation and death, making MTT indispensable in cancer research and regenerative medicine. Unlike dyes that require active transport or are subject to efflux, MTT’s cationic, membrane-permeable structure allows efficient cell entry without external facilitators.

Mechanism of Action of MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide)

MTT (chemical formula: C₁₈H₁₆BrN₅S, CAS 298-93-1) is reduced by NADH-dependent oxidoreductases primarily in mitochondria, but also by extra-mitochondrial enzymes (Chen et al., 2023). Upon entering viable cells, MTT accepts electrons from NADH or NADPH, resulting in the formation of insoluble purple formazan crystals. The reaction is quantitative and correlates directly with the number of metabolically active cells [site article]:

• MTT (yellow, soluble) + NADH → Formazan (purple, insoluble) + NAD⁺

Formazan crystals accumulate within cells and can be solubilized post-assay with DMSO or ethanol for spectrophotometric quantitation at 570 nm. This direct electron transfer mechanism is favored under physiological pH (7.2–7.4) and temperature (37°C).

Evidence & Benchmarks

• MTT is reduced specifically by viable, metabolically active cells, enabling quantitative assessment of cytotoxicity and proliferation (Chen et al., 2023, DOI).
• MTT assays demonstrate high sensitivity and reproducibility in measuring cell viability in cancer cell lines under standard in vitro conditions (Annexin V-FITC article).
• MTT reduction is predominantly mitochondrial, but significant extra-mitochondrial reduction can occur, depending on cell type and metabolic state (Annexin V-APC article).
• The assay is linear for cell counts ranging from 5 × 10³ to 5 × 10⁴ cells/well, with formazan production proportional to viable cell number (APExBIO product documentation, product page).
• MTT is stable at −20°C for at least 12 months; aqueous solutions should be freshly prepared and used within hours to prevent degradation (APExBIO B7777, product page).

Applications, Limits & Misconceptions

MTT is widely used for:

• High-throughput screening of anti-cancer drugs in 96- or 384-well plate formats.
• Quantitative assessment of apoptosis, proliferation, and metabolic activity in primary cells and established lines.
• Evaluating mitochondrial function and cytotoxicity in research-grade toxicology studies.

Its widespread adoption in cancer, immunology, and regenerative medicine is due to its robust signal, ease of use, and compatibility with automated workflows. For an expanded discussion on MTT’s role in translational research, see this article, which this page extends by detailing solution chemistry and storage stability under routine laboratory conditions.

Common Pitfalls or Misconceptions

• MTT reduction is not exclusively mitochondrial; non-mitochondrial enzymes can contribute to formazan formation, especially in certain tissue types.
• Dead cells and debris do not reduce MTT; thus, the assay cannot distinguish between cytostatic and cytotoxic effects.
• MTT is not suitable for use in vivo or for diagnostic/clinical applications; it is strictly for research use only (RUO).
• High reducing agents, antioxidants, or colored compounds in test wells can interfere with assay readouts.
• Formazan solubilization requires complete dissolution in DMSO or ethanol; incomplete dissolution leads to underestimation of viability.

Workflow Integration & Parameters

MTT is supplied by APExBIO at ≥98% purity (SKU B7777), supporting reproducible results in standard in vitro workflows. Key parameters:

• Solubility: ≥41.4 mg/mL in DMSO, ≥18.63 mg/mL in ethanol, ≥2.5 mg/mL in water (with ultrasonic assistance).
• Storage: −20°C; protect from light and moisture.
• Assay conditions: 0.5–1 mg/mL MTT working concentration, 2–4 hours incubation at 37°C, pH 7.2–7.4.
• Detection: Solubilize formazan in DMSO or ethanol, read absorbance at 570 nm (reference 630–690 nm).

For full details and troubleshooting, refer to the MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide) product page. For further reading on workflow optimization and advanced troubleshooting, see this article, which this page updates with recent solubility and benchmarking data.

Conclusion & Outlook

MTT remains the gold standard for in vitro cell viability, proliferation, and metabolic activity measurement, due to its robust performance, high sensitivity, and ease of integration into high-throughput workflows. The direct, NADH-dependent reduction mechanism provides a quantitative readout correlating with viable cell number. APExBIO’s high-purity MTT (B7777) ensures assay reproducibility and reliability across research domains. Continued optimization of cell-based assays and integration with complementary readouts (e.g., apoptosis markers, mitochondrial assays) will further enhance the utility of MTT in translational research and drug discovery.